NCT04971070 is a clinical trial of Observation and follow-up in Hypoglycemia, sponsored by Chongqing Renji Hospital, University of Chinese Academy of Sciences.

Who is sponsoring NCT04971070?

NCT04971070 is sponsored by Chongqing Renji Hospital, University of Chinese Academy of Sciences.

What drugs are being tested in NCT04971070?

Interventions in NCT04971070: Observation and follow-up.

What condition does NCT04971070 study?

NCT04971070 studies Hypoglycemia.

Is NCT04971070 still recruiting?

NCT04971070 is currently completed. Last updated 8 February 2023.

Last reviewed 2023-02-08 · How we verify

NCT04971070

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Analysis of Related Risk Factors of Hypoglycemia Consciousness Disorder

Completed Last updated 8 February 2023

What this trial tests

trial testing Observation and follow-up in Hypoglycemia in 292 participants. Completed in 15 January 2023.

Timeline

25 July 2021

Primary endpoint
20 February 2022

15 January 2023

Quick facts

Lead sponsor	Chongqing Renji Hospital, University of Chinese Academy of Sciences
Status	Completed
Study type	OBSERVATIONAL
Enrollment	292
Start date	25 July 2021
Primary completion	20 February 2022
Estimated completion	15 January 2023
Sites	1 location across China

Drugs / interventions tested

Observation and follow-up

Conditions studied

Hypoglycemia — all drugs for Hypoglycemia →

Sponsor

Chongqing Renji Hospital, University of Chinese Academy of Sciences

Who can join

Adults 18 to 80, any sex, with Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective to explore the high risk factors and inducements of consciousness disorder in patients with hypoglycemia, and to conduct a retrospective study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypoglycemia

Currently open trials in the same condition.

NCT06893341 — Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events · NA · recruiting
NCT07286500 — "Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glu · recruiting
NCT07082478 — External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia · recruiting
NCT06575426 — A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M · Phase 1, PHASE2 · recruiting
NCT06986603 — Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia · Phase 4 · active not recruiting

Other Chongqing Renji Hospital, University of Chinese Academy of Sciences trials

Trials by the same sponsor.

NCT04999722 — Establishment and Preliminary Evaluation of Digital Three Level Linkage Whole Process Diabetes Management System · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04971070 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chongqing Renji Hospital, University of Chinese Academy of Sciences
Last refreshed: 8 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04971070.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing